SMS Lifesciences India Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|
| Revenue | 87 | 88.65 | 71.87 |
| Operating Expense | 72.80 | 75.56 | 62.21 |
| Net Profit | 6.46 | 5.93 | 3.31 |
| Net Profit Margin | 7.43 | 6.69 | 4.61 |
| Earning Per Share | 21.37 | 19.63 | 10.96 |
| EBIDTA | 14.12 | 11.86 | 9.40 |
| Effective Tax Rate | 21.13 | 5.73 | 15.53 |
| Particulars | Jun 2024 |
|---|---|
| Revenue | 87.00 |
| Operating Expense | 72.80 |
| Net Profit | 6.46 |
| Net Profit Margin | 7.43 |
| Earning Per Share | 21.37 |
| EBIDTA | 14.12 |
| Effective Tax Rate | 21.13 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Total Revenue Annual | 315.24 | 345.63 | 260.26 |
| Operating Expenses Annual | 288.84 | 314.26 | 230.52 |
| Operating Profit Annual | 31.64 | 45.59 | 31.07 |
| Interest Annual | 5.09 | 4.63 | 4.50 |
| Depreciation | 7.53 | 7.51 | 6.70 |
| Net Profit Annual | 13.22 | 25.38 | 13.17 |
| Tax Annual | 5.15 | 7.60 | 6.19 |
| Particulars | Mar 2023 |
|---|---|
| Total Revenue Annual | 315.24 |
| Operating Expenses Annual | 288.84 |
| Operating Profit Annual | 31.64 |
| Interest Annual | 5.09 |
| Depreciation | 7.53 |
| Net Profit Annual | 13.22 |
| Tax Annual | 5.15 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.95 | 8.46 | 0.65 |
| Cash Flow from Operations | 4.58 | -14.66 | 21.62 |
| Cash Flow from Investing | -27.96 | -7.49 | -5.94 |
| Cash Flow from Financing | 22.59 | 14.63 | -7.87 |
| Cash Flow at the End | 0.15 | 0.95 | 8.46 |
| Particulars | Mar 2023 |
|---|---|
| Cash Flow at the Beginning | 0.95 |
| Cash Flow from Operations | 4.58 |
| Cash Flow from Investing | -27.96 |
| Cash Flow from Financing | 22.59 |
| Cash Flow at the End | 0.15 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| PBDIT Margin (%) | 8.34 | 8.67 | 10.85 |
| PBIT Margin (%) | 6.02 | 6.56 | 8.34 |
| PBT Margin (%) | 4.85 | 5.16 | 6.51 |
| Net PROFIT Margin (%) | 3.76 | 6.69 | 4.59 |
| Return On Networth / Equity (%) | 7.34 | 11.47 | 10.99 |
| Return On Networth /Employed (%) | 8.99 | 12.54 | 13.83 |
| Return On Assets (%) | 5.60 | 12.79 | 7.62 |
| Total Debt / Equity (X) | 0.47 | 0.39 | 0.40 |
| Asset Turnover Ratio (%) | 1.49 | 1.91 | 1.66 |
| Particulars | Mar 2023 |
|---|---|
| PBDIT Margin (%) | 8.34 |
| PBIT Margin (%) | 6.02 |
| PBT Margin (%) | 4.85 |
| Net PROFIT Margin (%) | 3.76 |
| Return On Networth / Equity (%) | 7.34 |
| Return On Networth /Employed (%) | 8.99 |
| Return On Assets (%) | 5.60 |
| Total Debt / Equity (X) | 0.47 |
| Asset Turnover Ratio (%) | 1.49 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Fixed Assets Annual | 139.61 | 98.72 | 100.83 |
| Total Current Assets Annual | 167.59 | 162.32 | 135.43 |
| Non Current Assets Annual | 169.80 | 149.68 | 136.32 |
| Total Shareholders Funds Annual | 164.03 | 151.21 | 126.34 |
| Total Assets Annual | 337.39 | 312.00 | 271.74 |
| Particulars | Mar 2023 |
|---|---|
| Fixed Assets Annual | 139.61 |
| Total Current Assets Annual | 167.59 |
| Non Current Assets Annual | 169.80 |
| Total Shareholders Funds Annual | 164.03 |
| Total Assets Annual | 337.39 |
EPS (INR)
Expected
23.18
Reported
23.15
Surprise
-0.13%
Mar 2024
EPS beaten by -0.13%
Dec 2023
EPS beaten by -0.05%
Sep 2023
EPS beaten by 0.00%
